First cast and thread. Why will science benefit from platforms like this one? - Coming from the field of cell therapy for hematology and oncology patients.

Immuno-oncology, researcher and clinician.

On-chain proofs: shared research results can be immediately available for community review and collaborative efforts. Results are perpetuated on chain, time-stamped.

Funding: direct transactions of funding to research labs, transparent without bs. Interested in a disease? Find active working groups, see how their projects are being developed in real time and sponsor them for the next experiment. (Unlikely to generate revenue, but) It would be possible to tokenize results.

Dissemination: knowledge is being shared and reviewed in real time. Everything is open access by default. No publication fees or journal pay-walls for readers to access work.

IP: ZNPs? Hash what must be preserved to secure future exploitation. But it's probably not that simple, I suppose.

Negative results: These platforms incentivise sharing negative results - in stark contrast with traditional publishing systems. Sharing a result is one cast away and then it can be up to the community to decide if it is a dead end (or not!!!).

Reproducibility: a community effort, much more powerful and valuable than one person repeating an experiment multiple times in the same lab settings.

I have seen multiple projects and DAOs working towards this goal. I hope some thrive and bring collaborative science to the next level. In the case of disease treatment, to me that ultimately means having a patient's interests above all else.

In the meanwhile I'll do my little part and build my projects openly here. Appreciate all support!

Channels: Focused medium to remove background noise, still accessible to anyone who wants to contribute to a specific topic.